Hp Halden Pharma

HP Halden Pharma AS is a contract development and manufacturing (CDMO) company for sterile and non-sterile pharmaceuticals, specialising in IV bags. Its capabilities include BFS ampoules and vials, non-sterile liquids, aseptic compounding and intestinal gel. Services also cover analytical method transfer and validation, process validation, stability testing, sterility testing, quality control, regulatory support and market release.

Customers are pharmaceutical companies worldwide, for whom the company manufactures products and supports technology transfer, scale-up and regulatory documentation. Each project is handled by a dedicated project manager. About 95% of its products are exported outside Norway, with global supply to more than 75 countries.

The company was founded in 2023 and is based in Halden, Norway, where its production site spans more than 77,000 m2, including a GMP area of more than 5,000 m2. The site's history dates back to 1977, when it was founded by Baxter. The website states a team of 700 employees representing 48 nationalities.

Product: Contract development and manufacturing of sterile and non-sterile pharmaceutical products, including IV bags, BFS ampoules and vials, and analytical and regulatory services.